Global Urea Breath Test Market By Test (Point-of-Care Tests (POCT), Laboratory-based Test), By Product (Breath Analyzer, UBT- kits), By Method (Mass Spectrometer, Infrared Spectrometer, Laser-assisted Rationalizer), By End-Users (Hospitals, Clinics, Diagnostic Centers, Standalone Labs, Private Lab Networks), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

The urea breath test is used to detect Helicobacter pylori (H. pylori), a bacterium that can infect the stomach and is the leading cause of stomach and duodenal ulcers (the first part of the small intestine). Urease is an enzyme produced by H. pylori that breaks down urea into carbon dioxide and ammonia. During the test, a urea tablet is swallowed, and the amount of carbon dioxide exhaled is measured. This shows that H. pylori are found in the stomach.

Detailed Segmentation –

The global urea breath test market is segmented on the basis of – Test Type, Product Type, Method, End-User, and Region. Represented below is a detailed segmental description:

Based on Test Type:

• Point-of-Care Tests (POCT)
• Laboratory-based Test

Based on Product Type:

• Breath Analyzer
• UBT- kits

Based on Method:

• Mass Spectrometer
• Infrared Spectrometer
• Laser-assisted Rationalizer

Based on End-User:

• Hospitals
• Clinics
• Diagnostic Centers
• Standalone Labs
• Private Lab Networks

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

Drivers for the Global Urea Breath Test Market:

Over the projected period, this market is expected to expand due to an increase in product approvals by regulatory bodies. For instance, the Gulf Coast Scientific Inc., a medical device company, stated in February 2020 that the Pylo Plus UBT System had been approved by the US Food & Drug Administration (FDA).

Pylo Plus UBT System is a 13C urea breath test for Helicobacter pylori (H. pylori) infection detection. Moreover, this market is expected to expand due to an increased focus on market tactics such as acquisitions and collaborations by key competitors. For example, in October 2016, MAYOLY SPINDLER, a leading pharmaceutical business, purchased Kibion, a leading manufacturer of urea breath test methods from Sweden.

MAYOLY expanded its product line with this acquisition, including Diabact UBT, Kibion’s C-13 Urea Breath Test, breath sample analyzers such as Heliprobe and Kibion Dynamic. Kibion also has a large presence in the Hpylori detection market in countries such as the UAE, Iran, and Germany. These are certain factors that will help augment this target market in the years to come.

Competitive Landscape –

Key players in this market are –

• Mayoli Spindler (Kibion AB)
• Otsuka Pharmaceutical Co. Ltd.
• Sercon Group
• Meridian Bioscience
• Paladin Labs Inc.
• Beijing Richen- Force Science & Technology Co. Ltd.
• Fisher Analysen Methode GmbH (FAN)
• Avanos Medical Inc.
• Beijing Binal Health Bio-Sci & Tech Co. Ltd
• Kizlon Medical
• Gulf Coast Scientific Inc.
• others

These key industry players are now focusing on mergers, partnerships, acquisitions, product developments, and collaboration strategies, in order to sustain their respective competitive edges.

Key Developments –

• Year 2019:
  • In Japan, Otsuka Pharmaceutical Co. Ltd. introduced the POConePlus Infrared Spectrophotometer for H. pylori detection. To find the absence or presence of H. pylori, the gadget monitors variations in the isotope ratio of carbon dioxide (13CO2 / 12CO2) present in exhaled breath.

For the Urea Breath Test Market research study, the following years have been considered to estimate the market size: